Skin and hair abnormalities of Cantu syndrome: A congenital hypertrichosis due to a genetic alteration mimicking the pharmacological effect of minoxidil.


Journal

The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 02 10 2019
accepted: 05 12 2019
pubmed: 8 1 2020
medline: 15 12 2020
entrez: 8 1 2020
Statut: ppublish

Résumé

Cantu syndrome is an autosomal dominant disorder, first described by Cantu in 1982, that is characterized by congenital hypertrichosis, characteristic facial anomalies and cardiomegaly. Recent investigations have revealed that this syndrome is caused by mutations of ABCC9, which encodes a regulatory subunit of SUR2, an adenosine triphosphate-mediated potassium channel opener, expressed not only in smooth muscle but also in hair follicles. However, the abnormalities of skin and hair in patients with Cantu syndrome have not been well explored. We herein report three Japanese patients with Cantu syndrome and describe their specific skin manifestations and alterations in the histopathology of their hair follicles and sebaceous glands. Similar alterations were shared among those three patients and may be related to the function of SUR2, namely the regulation of hair follicle growth, because SUR2 is a known pharmacological target of minoxidil.

Identifiants

pubmed: 31907964
doi: 10.1111/1346-8138.15216
doi:

Substances chimiques

ABCC9 protein, human 0
Antihypertensive Agents 0
Sulfonylurea Receptors 0
Minoxidil 5965120SH1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-310

Subventions

Organisme : the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research
ID : C, 17K10211

Informations de copyright

© 2020 Japanese Dermatological Association.

Références

Cantu JM, Sanchez-Corona J, Hernandes A, Nazara Z, Garcia-Cruz D. Individualization of a syndrome with mental deficiency, macrocranium, peculiar facies, and cardiac and skeletal anomalies. Clin Genet 1982; 22: 172-179.
Harakalova M, van Harssel JJ, Terhal PA et al. Dominant missense mutations in ABCC9 cause Cantu syndrome. Nat Genet 2012; 44: 793-796.
Davies GC, Thornton MJ, Jenner TJ et al. Novel and established potassium channel openers stimulate hair growth in vitro: implications for their modes of action in hair follicles. J Invest Dermatol 2005; 124: 686-694.
Shorter K, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J 2008; 22: 1725-1736.
Meisheri KD, Johnson GA, Puddington L. Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil. Biochem Pharmacol 1993; 45: 271-279.
Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004; 150: 186-194.
Hiraki Y, Miyatake S, Hayashidani M et al. Aortic aneurysm and craniosynostosis in a family with Cantu syndrome. Am J Med Genet A 2014; 164A: 231-236.
Carlesimo M, Cortesi G, Gamba A et al. Ehlers-Danlos syndrome: case report and an electron microscopy study. Rheumatol Int 2012; 32: 1507-1510.
van Bon BW, Gilissen C, Grange DK et al. Cantu syndrome is caused by mutations in ABCC9. Am J Hum Genet 2012; 90: 1094-1101.
Niemann C, Horsley V. Development and homeostasis of the sebaceous gland. Semin Cell Dev Biol 2012; 23: 928-936.
Nguyen KH, Marks JG Jr. Pseudoacromegaly induced by the long-term use of minoxidil. J Am Acad Dermatol 2003; 48: 962-965.

Auteurs

Kentaro Ohko (K)

Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.

Kimiko Nakajima (K)

Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.

Hideki Nakajima (H)

Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.

Yoko Hiraki (Y)

Hiroshima Municipal Center for Child Health and Development, Hiroshima, Japan.

Kazuo Kubota (K)

Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Division of Clinical Genetics, Gifu University Hospital, Gifu, Japan.

Toshiyuki Fukao (T)

Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Division of Clinical Genetics, Gifu University Hospital, Gifu, Japan.

Satoko Miyatake (S)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Shigetoshi Sano (S)

Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH